globalnews.ca
57%
497
Coronavirus drug approved for use in India on patients with moderate to severe symptoms
India coronavirus cases surpass half a million, with no end in sight The control group which did not receive Itolizumab unfortunately suffered deaths, she said, adding that the “first-in-class” drug will save lives and help reduce the mortality rate in India.Clinical studies involving the drug are being closely watched as nations look for treatments for the disease that has infected over 820,000 people and killed over 22,000 in India.India recorded 27,114 coronavirus cases in the last 24 hours.